NRIX Nurix Therapeutics, Inc.

HealthcareBiotechnology
$16.28
▼ 3.55%
35
QScore Signal
Short
Confidence: MEDIUM
Long-Term
26
Short-Term
44

Value

14
P/E-6.07
8
P/B3.73
46
P/S19.66
0
EV/EBITDA-4.84
5

Growth

63
Revenue Growth54.0%
100
EPS Growth-5.9%
43
FCF Growth-44.9%
39

Momentum

72
12-Month Return68.7%
98
3-Month Return2.1%
63
1-Month Return4.4%
61
RSI (14)35.39
50
50/200 MABullish
75

Profitability

8
ROE-64.2%
39
ROA-46.4%
0
Gross Margin-139.4%
0
Operating Margin-439.3%
0
Net Margin-411.4%
0
FCF Yield-19.3%
0

Risk

16
Beta1.88
35
60-Day Volatility43.0%
0

Generated 5/7/2026, 10:03:18 PM · How is this calculated?

QScore Analysis